I wouldn't be risking any fundamental outperformance. Just because the shares come out of escrow doesn't mean they will all be sold, especially if the share price is already weak going into the result.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor